XETRA:MED
Mediclin AG · XETRA · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 10:23 UTC
Last close
n/aEUR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
9.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
5.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
3.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
6.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.57Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Safety is the furthest below its sector's middle: 0.32 against 0.57 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.15x
Its own average over 10 years, 680.9M.
- Profit3.21x
Its own average over 10 years, 7.9M.
- Free cash flow1.78x
Its own average over 10 years, 29.0M.
- Debt1.13x
Its own average over 10 years, 346.3M.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 3.21 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 105.0 | 23.6 | 100.0 |
| 2018-12-31 | 111.2 | 46.6 | 100.0 |
| 2019-12-31 | 116.0 | 58.4 | 100.0 |
| 2020-12-31 | 113.7 | -54.4 | 100.0 |
| 2021-12-31 | 116.0 | 8.8 | 100.0 |
| 2022-12-31 | 121.4 | 57.1 | 100.0 |
| 2023-12-31 | 125.8 | -65.1 | 100.0 |
| 2024-12-31 | 129.0 | 150.1 | 100.0 |
| 2025-12-31 | 135.2 | 154.0 | 100.0 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Figures behind the shape
Growth
3.5%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate3.5%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
One-year change in net income2.6%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Returns on capital
5.0%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital5.0%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity10.2%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets2.9%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
14.5%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin14.5%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin4.9%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin3.3%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin6.6%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
9.9xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings9.9x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
Price to book1.0x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA5.8x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.3x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
1.57safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity1.57
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.62
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage1.9x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score1.54
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
7.5%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Payout ratio7.5%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio27.1x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.